Literature DB >> 8903102

Changes in concentrations of methylglyoxal, D-lactate and glyoxalase activities in liver and plasma of rats fed a 3'-methyl-4-dimethylaminoazobenzene-rich diet.

M Kawase1, M Tada, S Akagi, S Ohmori.   

Abstract

Donryu male albino rats were fed a diet containing 0.064% 3'-methyl-4-dimethylaminoazobenzene (MDAB) for 21 weeks. During the ensuing rat liver carcinogenesis, changes in the concentrations of methylglyoxal, D-lactate and glutathione as well as activities of glyoxalase I and II in liver and plasma were examined. After the start of the diet, hepatic contents of methylglyoxal and D-lactate increased to about 7 and 3 times that of the control, respectively. However, after 21 weeks the D-lactate content decreased from the elevated level, but remained at a higher level of 1.4 times the control. The hepatic glyoxalase I activity increased 1.2 to 1.7 times over the control during carcinogenesis, while glyoxalase II activity increased 160% during the precancerous state and decreased to 55% of control at 21 weeks. the hepatic level of reduced glutathione (GSH) increased and peaked after 4 weeks of the MDAB diet and decreased thereafter to 57% of the control level after 21 weeks. Both pyruvate and L-lactate levels increased in the liver and plasma of MDAB-fed rats when rats had obvious symptoms of hepatoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8903102     DOI: 10.1007/bf02576849

Source DB:  PubMed          Journal:  Res Exp Med (Berl)        ISSN: 0300-9130


  2 in total

1.  GLO1 overexpression in human malignant melanoma.

Authors:  Warner B Bair; Christopher M Cabello; Koji Uchida; Alexandra S Bause; Georg T Wondrak
Journal:  Melanoma Res       Date:  2010-04       Impact factor: 3.599

2.  The glucose metabolite methylglyoxal inhibits expression of the glucose transporter genes by inactivating the cell surface glucose sensors Rgt2 and Snf3 in yeast.

Authors:  Adhiraj Roy; Salman Hashmi; Zerui Li; Angela D Dement; Kyu Hong Cho; Jeong-Ho Kim
Journal:  Mol Biol Cell       Date:  2016-01-13       Impact factor: 4.138

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.